The administration’s December 2025 directive to reclassify marijuana from Schedule I to Schedule III represents the most significant cannabis policy shift in 50 years. For cannabis business owners, this isn’t just regulatory housekeeping—it potentially unlocks between $1.6 billion and $2.2 billion in after-tax cash flow across the industry.
But here’s what nobody’s telling you: rescheduling doesn’t solve your accounting problems. It just changes which problems you have.
Section 280E of the Internal Revenue Code has been the invisible tax that’s been bleeding cannabis businesses since day one. The rule is simple and brutal: if you traffic in Schedule I or II controlled substances, you can’t deduct ordinary business expenses on your federal tax returns.
Your landlord got paid? Not deductible. Your marketing budget? Not deductible. Payroll for everyone except production staff? Also not deductible. You could only claim cost of goods sold, which meant cannabis companies effectively paid taxes on gross profit instead of net income like every other business.
The math got ugly fast. Traditional retailers operate on 9-12% net margins and pay taxes accordingly. Cannabis dispensaries often showed 40-50% “taxable income” because they couldn’t deduct operating expenses, even when actual profitability was single digits.
While Congress has not repealed Section 280E itself, rescheduling to Schedule III removes cannabis from the category of substances to which 280E applies — effectively neutralizing it. When marijuana moves to Schedule III, those restrictions disappear. Suddenly, rent becomes deductible. Marketing expenses become deductible. Your entire operational expense structure gets treated like a normal business.
Before you celebrate, understand what rescheduling doesn’t fix.
While 78% of Americans now live in a county with at least one dispensary, most banks still treat cannabis businesses like radioactive material. Even with rescheduling momentum, a significant percentage of banks remain hesitant — surveys show between 20– 45% of financial institutions remain “unsure” about entering the cannabis banking market.
Cash-intensive operations create accounting nightmares that software alone can’t solve. Every transaction needs bulletproof documentation for both state regulators and the IRS. Manual cash counting introduces error rates that would be career-ending in other industries. And when you’re dealing with millions in revenue flowing through armored cars instead of ACH transfers, your accounting complexity multiplies exponentially.
Adult-use cannabis is legal in 24 states. Medical marijuana operates in 42 states. That’s 42 different regulatory frameworks, 42 different compliance requirements, and 42 different ways your accounting needs to function.
California alone has 3,659 dispensaries—more than double the number of the second-highest state. Each one navigates different municipal regulations in addition to state requirements. Your chart of accounts needs to track compliance across jurisdictions that don’t communicate with each other and often contradict each other’s rules.
Cannabis inventory management operates under regulatory scrutiny that makes food safety protocols look relaxed. Seed-to-sale tracking means every gram needs documentation from cultivation through final sale. Shrinkage isn’t just a margin issue—it’s a compliance event that could trigger investigations.
Cost accounting becomes even more critical post-rescheduling — IRS audits of cannabis businesses have historically focused on COGS methodologies, capitalization policies, and inventory valuation under 471 and 263A.. The U.S. cannabis industry hit $31.5 billion in sales in 2025, with flower and pre-rolls accounting for the bulk of transactions. When you’re managing inventory across multiple product categories, batch tracking, expiration dates, and compliance requirements, manual accounting becomes impossible.
This complexity compounds when you cross into edibles, beverages, and infused products — categories that blend cannabis regulations with traditional CPG manufacturing challenges. Yield loss, batch costing, freight allocation, and channel mix distortions can swing margins by double digits if your costing model isn’t designed for both cannabis compliance and CPG production reality.
Cultivation and manufacturing operators face additional complexity: biological asset accounting, yield forecasting, byproduct allocation, and batch-level costing that must satisfy both state regulators and IRS auditors. Flower, trim, concentrates, and derivative products all follow different cost pathways, and misallocations at the grow or processing stage cascade into retail margins — especially for vertically integrated operators.
The cannabis businesses that thrive financially share three characteristics:
Even under 280E restrictions, proper cost allocation made the difference between viable and doomed. Tax Court cases like Harborside v. Commissioner established that structure matters—businesses operating multiple “trades” can potentially allocate expenses differently than single-purpose cannabis retailers.
This isn’t academic. Proper cost accounting under 280E meant documenting every dollar of COGS with forensic precision. Post-rescheduling, that discipline remains essential for maximizing deductions while maintaining audit-proof records.
Cannabis operators scaling beyond a single location need accounting systems that handle different state tax structures, varying compliance requirements, and location-specific regulations without breaking.
This means cloud-based accounting platforms that integrate with compliance tracking systems, automated reconciliation that catches discrepancies before they become violations, and financial reporting that breaks down performance by location and jurisdiction.
Limited banking access isn’t going away overnight. Smart operators build internal controls that would satisfy anti-money laundering requirements at major financial institutions, implement segregation of duties that prevents fraud in cash-intensive environments, and maintain documentation standards that exceed what banks require—because those same standards satisfy IRS auditors.
Here’s the reality cannabis business owners face: you need controller-level expertise to navigate complex compliance requirements, but you probably can’t justify a $150K+ full-time controller just for bookkeeping and tax compliance.
That’s where co-sourced financial services create breathing room.
Co-sourced accounting means experienced professionals who understand both cannabis-specific regulations and modern financial operations plug directly into your existing team. You maintain oversight and control. They bring specialized expertise in 280E optimization, multi-state compliance, inventory accounting, and banking documentation requirements.
The model works because cannabis businesses need high-level strategic guidance without necessarily needing a full-time executive on payroll. A fractional controller who’s worked with 20 cannabis companies brings pattern recognition your first-time-hire internal candidate simply can’t match.
Beyond rescheduling, cannabis accounting in 2026 faces three major shifts:
Manual transaction coding and compliance tracking can’t scale with the industry’s growth trajectory. Cannabis businesses are adopting AI-driven platforms that categorize expenses, flag potential compliance issues, and generate jurisdiction-specific reports automatically.
These aren’t future-state technologies. They exist now, and the businesses implementing them are closing books 40% faster while reducing audit adjustments by similar margins.
Of course, none of these AI tools work without disciplined underlying data. Inconsistent SKU naming, bad cash logs, non-standard units of measure, and mismapped METRC categories will simply generate inaccurate compliance reports faster. AI amplifies good accounting — it does not replace it.
As cannabis matures, institutional investors expect institutional-grade financial reporting. That means audited financials, defensible internal controls, and accounting practices that would pass scrutiny at a publicly traded company.
Most cannabis entrepreneurs didn’t start their businesses to become accounting experts. But if you want growth capital, your financials need to tell a story that CFOs at venture firms and private equity funds can trust.
Rescheduling unlocks traditional tax planning strategies that cannabis businesses couldn’t access before. Depreciation schedules, retirement plan contributions, and business structure decisions all change when you’re no longer treated as a criminal enterprise for tax purposes.
The businesses that move quickly to restructure their tax strategies will capture advantages competitors miss while they’re still celebrating 280E’s demise.
Wiss provides co-sourced financial leadership services tailored to the unique complexities cannabis businesses face. We’re not trying to replace your existing team—we’re giving them controller and CFO-level expertise they can deploy exactly when and where it’s needed.
That means Section 280E optimization strategies that maximize deductions under current rules while positioning you for rescheduling benefits, multi-state compliance tracking across jurisdictions, inventory accounting systems that satisfy both regulators and investors, and banking documentation that meets institutional standards even when traditional banks won’t work with you.
Cannabis businesses exist in regulatory gray areas that traditional accounting firms don’t understand and won’t touch. We built our cannabis practice specifically to navigate the intersection of legitimate business operations and the contradictions between federal and state policies.
Your cannabis business deserves financial infrastructure that matches your operational sophistication. You’re not running a black-market operation—you shouldn’t have accounting systems that look like one.
Contact Wiss to discuss how co-sourced financial leadership can help you optimize compliance, maximize the benefits of cannabis rescheduling, and build financial operations that support institutional growth.